Alix-Panabières C - Search Results

1

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma.

Ruano APC, Gadelha Guimarães AP, Braun AC, Flores BCTCP, Tariki MS, Abdallah EA, Torres JA, Nunes DN, Tirapelli B, de Lima VCC, Fanelli MF, Colombo PE, da Costa AABA, Alix-Panabières C, Chinen LTD. Ruano APC, et al. Int J Mol Sci. 2022 Nov 24;23(23):14687. doi: 10.3390/ijms232314687. Int J Mol Sci. 2022. PMID: 36499015 Free PMC article.

2

Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy.

Fournier AM, Baillat V, Alix-Panabieres C, Fondere JM, Merle C, Segondy M, Huguet MF, Reynes J, Vendrell JP. Fournier AM, et al. AIDS. 2002 Sep 6;16(13):1755-60. doi: 10.1097/00002030-200209060-00007. AIDS. 2002. PMID: 12218386

3

Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

Müller I, Beeger C, Alix-Panabières C, Rebillard X, Pantel K, Schwarzenbach H. Müller I, et al. Clin Chem. 2008 Apr;54(4):688-96. doi: 10.1373/clinchem.2007.099333. Epub 2008 Feb 15. Clin Chem. 2008. PMID: 18281424

4

Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells.

Fournier AM, Fondere JM, Alix-Panabieres C, Merle C, Baillat V, Huguet MF, Taïb J, Ohayon V, Zembala M, Reynes J, Vendrell JP. Fournier AM, et al. Clin Immunol. 2002 Apr;103(1):98-109. doi: 10.1006/clim.2001.5195. Clin Immunol. 2002. PMID: 11987990

5

Circulating tumor cells and bone marrow micrometastasis.

Alix-Panabières C, Riethdorf S, Pantel K. Alix-Panabières C, et al. Clin Cancer Res. 2008 Aug 15;14(16):5013-21. doi: 10.1158/1078-0432.CCR-07-5125. Clin Cancer Res. 2008. PMID: 18698019 Review.

6

Circulating tumour cells in cancer patients: challenges and perspectives.

Pantel K, Alix-Panabières C. Pantel K, et al. Trends Mol Med. 2010 Sep;16(9):398-406. doi: 10.1016/j.molmed.2010.07.001. Epub 2010 Jul 29. Trends Mol Med. 2010. PMID: 20667783 Review.

7

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

Doyen J, Alix-Panabières C, Hofman P, Parks SK, Chamorey E, Naman H, Hannoun-Lévi JM. Doyen J, et al. Crit Rev Oncol Hematol. 2012 Mar;81(3):241-56. doi: 10.1016/j.critrevonc.2011.05.004. Epub 2011 Jun 15. Crit Rev Oncol Hematol. 2012. PMID: 21680196 Review.

8

Circulating tumor cells and circulating tumor DNA.

Alix-Panabières C, Schwarzenbach H, Pantel K. Alix-Panabières C, et al. Annu Rev Med. 2012;63:199-215. doi: 10.1146/annurev-med-062310-094219. Epub 2011 Nov 2. Annu Rev Med. 2012. PMID: 22053740 Review.

9

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.

Alix-Panabières C. Alix-Panabières C. Recent Results Cancer Res. 2012;195:69-76. doi: 10.1007/978-3-642-28160-0_6. Recent Results Cancer Res. 2012. PMID: 22527495 Review.

10

Circulating tumor cells: liquid biopsy of cancer.

Alix-Panabières C, Pantel K. Alix-Panabières C, et al. Clin Chem. 2013 Jan;59(1):110-8. doi: 10.1373/clinchem.2012.194258. Epub 2012 Sep 26. Clin Chem. 2013. PMID: 23014601 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page